These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei. Barnes JL; Warner J; Melrose W; Durrheim D; Speare R; Reeder JC; Ketheesan N Clin Immunol; 2004 Oct; 113(1):22-8. PubMed ID: 15380526 [TBL] [Abstract][Full Text] [Related]
11. Diabetes and Infectious Diseases with a Focus on Melioidosis. Uthaya Kumar A; Ahmad Zan M; Ng CL; Chieng S; Nathan S Curr Microbiol; 2024 Jun; 81(7):208. PubMed ID: 38833191 [TBL] [Abstract][Full Text] [Related]
12. Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity. Morris J; Williams N; Rush C; Govan B; Sangla K; Norton R; Ketheesan N Infect Immun; 2012 Jun; 80(6):2089-99. PubMed ID: 22473609 [TBL] [Abstract][Full Text] [Related]
13. Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins. Nithichanon A; Gourlay LJ; Bancroft GJ; Ato M; Takahashi Y; Lertmemongkolchai G Immunology; 2017 May; 151(1):98-109. PubMed ID: 28066900 [TBL] [Abstract][Full Text] [Related]
14. Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Wiersinga WJ; Wieland CW; van der Windt GJ; de Boer A; Florquin S; Dondorp A; Day NP; Peacock SJ; van der Poll T Infect Immun; 2007 Aug; 75(8):3739-46. PubMed ID: 17517876 [TBL] [Abstract][Full Text] [Related]
15. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688 [TBL] [Abstract][Full Text] [Related]
16. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517 [TBL] [Abstract][Full Text] [Related]
17. Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis. Suwannasaen D; Mahawantung J; Chaowagul W; Limmathurotsakul D; Felgner PL; Davies H; Bancroft GJ; Titball RW; Lertmemongkolchai G J Infect Dis; 2011 Apr; 203(7):1002-11. PubMed ID: 21300673 [TBL] [Abstract][Full Text] [Related]
19. Role of Burkholderia pseudomallei-Specific IgG2 in Adults with Acute Melioidosis, Thailand. Chaichana P; Jenjaroen K; Chumseng S; Sumonwiriya M; Rongkard P; Kronsteiner B; Teparrukkul P; Limmathurotsakul D; Day NPJ; Chantratita N; Dunachie SJ Emerg Infect Dis; 2021 Feb; 27(2):463-470. PubMed ID: 33496230 [TBL] [Abstract][Full Text] [Related]
20. A nonsense mutation in TLR5 is associated with survival and reduced IL-10 and TNF-α levels in human melioidosis. Chaichana P; Chantratita N; Brod F; Koosakulnirand S; Jenjaroen K; Chumseng S; Sumonwiriya M; Burtnick MN; Brett PJ; Teparrukkul P; Limmathurotsakul D; Day NPJ; Dunachie SJ; West TE PLoS Negl Trop Dis; 2017 May; 11(5):e0005587. PubMed ID: 28475641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]